Phone-delivered mindfulness training to promote medication adherence and reduce sexual risk behavior among persons living with HIV: Design and methods.

Elena Salmoirago-Blotcher, Carla Rich, Rochelle K Rosen, Shira Dunsiger, Aadia Rana, Michael P Carey
Author Information
  1. Elena Salmoirago-Blotcher: Centers for Behavioral and Preventive Medicine, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02903, United States; Department of Medicine, The Warren Alpert Medical School of Brown University, United States. Electronic address: Elena_Salmoirago-Blotcher@brown.edu.
  2. Carla Rich: Centers for Behavioral and Preventive Medicine, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02903, United States.
  3. Rochelle K Rosen: Centers for Behavioral and Preventive Medicine, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02903, United States; Department of Behavioral and Social Science, School of Public Health, Brown University, United States.
  4. Shira Dunsiger: Centers for Behavioral and Preventive Medicine, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02903, United States; Department of Behavioral and Social Science, School of Public Health, Brown University, United States.
  5. Aadia Rana: Department of Medicine, The Warren Alpert Medical School of Brown University, United States.
  6. Michael P Carey: Centers for Behavioral and Preventive Medicine, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02903, United States; Department of Behavioral and Social Science, School of Public Health, Brown University, United States; Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, United States.

Abstract

INTRODUCTION: Two-thirds of people living with HIV (PLWH) show sub-optimal adherence to antiretroviral therapy (ART) and one-third engages in risky sex. Both non-adherence and risky sex have been associated with emotional distress and impulsivity. To allay distress and lessen impulsivity, mindfulness training (MT) can be helpful. In this trial, we will investigate the utility of phone-delivered MT for PWLH. The primary outcomes comprise feasibility and acceptability of phone-delivery; secondary outcomes are estimates of efficacy of MT on adherence to ART and safer sexual practices as well as on their hypothesized antecedents.
METHODS/DESIGN: Fifty participants will be enrolled in this parallel-group randomized clinical trial (RCT). Outpatients recruited from an HIV treatment clinic will be randomized (1:1 ratio) to either MT or to an attention-control intervention; both interventions will be administered during 8 weekly phone calls. ART adherence (self-reported measure and unannounced phone pill counts), sexual behavior (self-reports and biomarkers), mindfulness, depression, stress, and impulsivity will be measured at baseline, post-intervention, and 3months post-intervention.
CONCLUSIONS: MT has great potential to help PLWH to manage stress, depressive symptoms, and impulsivity. Positive changes in these antecedents are expected to improve safer sex practices and ART adherence. If results from this exploratory trial support our hypotheses, we will conduct a large RCT to test (a) the efficacy of MT on ART adherence and safer sex practices and (b) the hypothesis that improved ART adherence and safer sex will reduce viral load, and decrease the incidence of sexually transmitted infections, respectively.

Keywords

References

  1. Health Psychol. 2004 Sep;23(5):443-51 [PMID: 15367063]
  2. J Gen Intern Med. 2001 Sep;16(9):606-13 [PMID: 11556941]
  3. J Biomed Inform. 2009 Apr;42(2):377-81 [PMID: 18929686]
  4. HIV Clin Trials. 2010 Nov-Dec;11(6):325-31 [PMID: 21239360]
  5. J Behav Med. 2014 Feb;37(1):166-72 [PMID: 23180286]
  6. Alcohol Clin Exp Res. 2007 Feb;31(2):185-99 [PMID: 17250609]
  7. Health Psychol Rev. 2015;9(2):224-43 [PMID: 26209210]
  8. Med Care. 1988 Jul;26(7):724-35 [PMID: 3393032]
  9. Evid Based Complement Alternat Med. 2012;2012:972106 [PMID: 22536294]
  10. AIDS. 2008 Jul 11;22(11):1345-54 [PMID: 18580614]
  11. PLoS One. 2014 Mar 24;9(3):e92842 [PMID: 24663122]
  12. Curr HIV/AIDS Rep. 2007 May;4(2):65-72 [PMID: 17547827]
  13. J Behav Med. 2012 Jun;35(3):272-85 [PMID: 21597980]
  14. Sex Transm Dis. 2000 Mar;27(3):127-32 [PMID: 10726643]
  15. J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):579-86 [PMID: 24378726]
  16. JAMA Intern Med. 2014 Mar;174(3):357-68 [PMID: 24395196]
  17. AIDS Behav. 2015 Jul;19(7):1228-46 [PMID: 25433653]
  18. Psychosom Med. 2012 Jul-Aug;74(6):620-7 [PMID: 22753635]
  19. AIDS Behav. 2014 Dec;18(12):2349-58 [PMID: 24077970]
  20. Addict Behav. 1982;7(4):363-71 [PMID: 7183189]
  21. J Intern Med. 2007 Mar;261(3):268-75 [PMID: 17305649]
  22. Clin Infect Dis. 2013 Oct;57(8):1164-71 [PMID: 23797289]
  23. J Gen Intern Med. 2012 Sep;27(9):1159-64 [PMID: 22528619]
  24. PLoS One. 2014 Jan 30;9(1):e87139 [PMID: 24498030]
  25. Arch Sex Behav. 2014 Aug;43(6):1149-58 [PMID: 24958252]
  26. Behav Med. 2015 Dec 11;:1-12 [PMID: 26651852]
  27. Arch Fam Med. 1995 Mar;4(3):211-9 [PMID: 7881602]
  28. AIDS Behav. 2014 Nov;18(11):2207-18 [PMID: 24906531]
  29. J Homosex. 2015;62(5):588-603 [PMID: 25402550]
  30. Psychol Assess. 2013 Mar;25(1):216-26 [PMID: 23148649]
  31. J Clin Psychol. 2014 Apr;70(4):313-21 [PMID: 23852856]
  32. Addict Behav. 2012 Oct;37(10):1084-92 [PMID: 22658304]
  33. Prim Health Care. 2014 Mar 1;4(1):152 [PMID: 25309826]
  34. MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1113-7 [PMID: 25426654]
  35. Psychosom Med. 2010 Oct;72(8):810-6 [PMID: 20716711]
  36. J Sex Res. 2013;50(5):480-8 [PMID: 22456443]
  37. Ann Behav Med. 2013 Oct;46(2):243-50 [PMID: 23605175]
  38. Explore (NY). 2008 Jan-Feb;4(1):36-7 [PMID: 18194789]
  39. JAMA. 2001 Mar 21;285(11):1466-74 [PMID: 11255423]
  40. Psychol Bull. 2003 Sep;129(5):674-97 [PMID: 12956539]
  41. Health Psychol. 2014 Jul;33(7):660-7 [PMID: 23957898]
  42. Psychosomatics. 2009 Nov-Dec;50(6):613-21 [PMID: 19996233]
  43. J Urban Health. 2014 Feb;91(1):151-61 [PMID: 23749458]
  44. Clin Infect Dis. 2007 Jun 1;44(11):1493-9 [PMID: 17479948]
  45. Psychol Assess. 2016 Jul;28(7):791-802 [PMID: 27078186]
  46. BMC Fam Pract. 2006 Mar 24;7:21 [PMID: 16563164]
  47. Am J Public Health. 1999 Aug;89(8):1231-4 [PMID: 10432912]
  48. AIDS Behav. 2014 Dec;18(12):2265-73 [PMID: 25331265]
  49. HIV Clin Trials. 2008 Sep-Oct;9(5):298-308 [PMID: 18977718]
  50. J Pain Symptom Manage. 2012 Feb;43(2):161-71 [PMID: 21925831]
  51. Health Psychol. 2008 Mar;27(2):129-39 [PMID: 18377131]
  52. J Gen Intern Med. 2007 Jul;22(7):1003-6 [PMID: 17390095]
  53. Appetite. 2011 Apr;56(2):241-8 [PMID: 21146571]
  54. J Altern Complement Med. 2003 Oct;9(5):683-94 [PMID: 14629846]
  55. J Pers Assess. 1990 Winter;55(3-4):610-7 [PMID: 2280326]
  56. AIDS Behav. 2014 Dec;18(12):2285-90 [PMID: 25280447]
  57. AIDS Behav. 2014 Feb;18(2):398-410 [PMID: 23835736]
  58. AIDS Behav. 2012 Nov;16(8):2119-43 [PMID: 22644066]
  59. J Clin Psychol. 2006 Mar;62(3):373-86 [PMID: 16385481]
  60. AIDS. 2009 Aug 24;23(13):1617-29 [PMID: 19584704]
  61. AIDS Behav. 2013 Sep 28;18(4):676-685 [PMID: 24077971]
  62. Eval Program Plann. 1979;2(3):197-207 [PMID: 10245370]
  63. Ann Behav Med. 2011 Dec;42(3):352-60 [PMID: 21818528]
  64. Front Neurosci. 2013 Feb 04;7:8 [PMID: 23382709]
  65. Acta Med Iran. 2010 Mar-Apr;48(2):101-6 [PMID: 21133002]
  66. Psychol Bull. 2009 Sep;135(5):707-30 [PMID: 19702379]
  67. Psychiatry Res. 1989 May;28(2):193-213 [PMID: 2748771]
  68. Brain Behav Immun. 2009 Feb;23(2):184-8 [PMID: 18678242]
  69. Curr HIV/AIDS Rep. 2014 Sep;11(3):291-307 [PMID: 25038748]
  70. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):181-7 [PMID: 21857529]
  71. J Consult Clin Psychol. 2010 Apr;78(2):169-83 [PMID: 20350028]
  72. Arch Gen Psychiatry. 2006 May;63(5):484-9 [PMID: 16651505]
  73. BMC Med. 2014 Aug 21;12:142 [PMID: 25145556]
  74. AIDS Patient Care STDS. 2009 Nov;23(11):903-14 [PMID: 19642921]

Grants

  1. K23 MH100955/NIMH NIH HHS
  2. R34 AT008930/NCCIH NIH HHS

MeSH Term

Anti-HIV Agents
Depression
Feasibility Studies
HIV Infections
Humans
Impulsive Behavior
Medication Adherence
Mindfulness
Patient Acceptance of Health Care
Risk-Taking
Sexual Behavior
Stress, Psychological
Telephone

Chemicals

Anti-HIV Agents

Word Cloud

Created with Highcharts 10.0.0adherencewillARTMTseximpulsivitytrialsaferHIVmindfulnesssexualpracticesbehaviorlivingPLWHriskydistresstrainingoutcomesefficacyantecedentsrandomizedRCTphonestresspost-interventionreduceriskINTRODUCTION:Two-thirdspeopleshowsub-optimalantiretroviraltherapyone-thirdengagesnon-adherenceassociatedemotionalallaylessencanhelpfulinvestigateutilityphone-deliveredPWLHprimarycomprisefeasibilityacceptabilityphone-deliverysecondaryestimateswellhypothesizedMETHODS/DESIGN:Fiftyparticipantsenrolledparallel-groupclinicalOutpatientsrecruitedtreatmentclinic1:1ratioeitherattention-controlinterventioninterventionsadministered8weeklycallsself-reportedmeasureunannouncedpillcountsself-reportsbiomarkersdepressionmeasuredbaseline3monthsCONCLUSIONS:greatpotentialhelpmanagedepressivesymptomsPositivechangesexpectedimproveresultsexploratorysupporthypothesesconductlargetestbhypothesisimprovedviralloaddecreaseincidencesexuallytransmittedinfectionsrespectivelyPhone-deliveredpromotemedicationamongpersonsHIV:DesignmethodsAdherenceClinicalMindfulnessSexualStress

Similar Articles

Cited By (5)